Sudarshan Pharma Industries
Sudarshan Pharma Industries Share Price Chart
Sudarshan Pharma Industries last traded at ₹38.71 (2026-10-13). Over the past month the stock moved -1.9%, three months the stock moved +9.1%, year the stock moved +32.9%. Its closing range over 52 weeks is ₹20.00 – ₹42.19, with the latest close 8.2% below the high.
Closing prices up to 2026-10-13.
About Sudarshan Pharma Industries
Incorporated in 2008, Sudarshan Pharma Industries Ltd manufactures API and Pharmaceutical Items. It also trades in Chemicals and Solvents[1]
Business Overview:[1][2] SPIL does jobwork manufacturing in pharmaceutical Items and trading in chemicals and solvents in India. It specializes in a host of products from rock chemicals intermediates and API to finish formulations and fully integrated pharmaceutical and chemicals
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Sudarshan Pharma Industries reported sales of ₹174.42 crore (+20.1%) and net profit of ₹5.61 crore (+41.7%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 174.42 | 15.90 | 9.12 | 5.61 | 0.24 |
| Mar 2026 | 220.92 | 20.20 | 9.14 | 11.40 | 0.45 |
| Dec 2025 | 168.01 | 10.87 | 6.47 | 4.15 | 0.18 |
| Sep 2025 | 168.87 | 9.21 | 5.45 | 3.87 | 0.17 |
| Jun 2025 | 145.26 | 11.04 | 7.60 | 3.96 | 0.17 |
| Mar 2025 | 161.59 | 15.93 | 9.86 | 7.41 | 0.31 |
| Dec 2024 | 115.66 | 7.97 | 6.89 | 2.88 | 0.12 |
| Sep 2024 | 128.58 | 13.05 | 10.15 | 5.88 | 0.24 |
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales growth | +46.4% | +31.3% | +45.3% | +36.7% | +20.1% |
| Operating profit growth | +430.8% | -29.4% | +36.4% | +26.8% | +44.0% |
| Net profit growth | – | -34.2% | +44.1% | +53.8% | +41.7% |
| EPS growth | – | -29.2% | +50.0% | +45.2% | +41.2% |
| OPM % | 7.6% | 5.5% | 6.5% | 9.1% | 9.1% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Sudarshan Pharma Industries reported sales of ₹703.00 crore (+39.2%) and net profit of ₹23.00 crore (+43.8%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 703.00 | 51.00 | 7.00 | 23.00 | 0.97 |
| Mar 2025 | 505.00 | 40.00 | 8.00 | 16.00 | 0.66 |
| Mar 2024 | 464.00 | 23.00 | 5.00 | 11.00 | 0.48 |
| Mar 2023 | 461.00 | 15.00 | 3.00 | 7.00 | 0.29 |
| Mar 2022 | 357.00 | 11.00 | 3.00 | 5.00 | 0.54 |
| Mar 2021 | 193.00 | 7.00 | 4.00 | 3.00 | 0.28 |
| Mar 2020 | 148.00 | 5.00 | 3.00 | 1.00 | 0.13 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales growth | +30.4% | +85.0% | +29.1% | +0.7% | +8.8% | +39.2% |
| Operating profit growth | +40.0% | +57.1% | +36.4% | +53.3% | +73.9% | +27.5% |
| Net profit growth | +200.0% | +66.7% | +40.0% | +57.1% | +45.5% | +43.8% |
| EPS growth | +115.4% | +92.9% | -46.3% | +65.5% | +37.5% | +47.0% |
| OPM % | 4.0% | 3.0% | 3.0% | 5.0% | 8.0% | 7.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Sudarshan Pharma Industries.
Get Free AI Stock Analysis FREE →Latest News
-
Sudarshan Pharma exits Ishwari Healthcare after ₹1.40 crore stake sale - scanx.trade
-
Sudarshan Pharma hits the roof on acquiring 9.5% stake in cancer therapy firm MedTherapy Biotech - Business Standard
-
Sudarshan Pharma approves 9.50% stake in US firm MedTherapy Biotech - scanx.trade
-
Sudarshan Pharma Industries Limited Publishes Audited Financial Results for Q4 FY26 and Full Year Ended 31st March 2026 - scanx.trade
-
Sudarshan Pharma Industries Limited Publishes Audited Financial Results for Q4 FY26 and Full Year Ended 31st March 2026 - scanx.trade
-
Sudarshan Pharma Industries Limited Publishes Audited Financial Results for Q4 FY26 and Full Year Ended 31st March 2026 - scanx.trade
-
Sudarshan Pharma Industries consolidated net profit rises 44.80% in the March 2026 quarter - Business Standard
-
Sudarshan Pharma Industries consolidated net profit rises 44.80% in the March 2026 quarter - Business Standard
-
Sudarshan Pharma Industries consolidated net profit rises 44.80% in the March 2026 quarter - Business Standard
-
Sudarshan Pharma Industries consolidated net profit rises 44.80% in the March 2026 quarter - Business Standard
Frequently Asked Questions
What is Sudarshan Pharma Industries's current stock price?
Sudarshan Pharma Industries shares were last quoted at ₹38.71 (+3.2% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Sudarshan Pharma Industries?
Sudarshan Pharma Industries has a price-to-earnings (P/E) ratio of 37.75 and a price-to-book (P/B) ratio of 5.77. The industry P/E is 53.33.
What is the 52-week high and low of Sudarshan Pharma Industries?
The 52-week high of Sudarshan Pharma Industries is ₹42.79 and the 52-week low is ₹18.50.
What is the market cap of Sudarshan Pharma Industries?
The market capitalisation of Sudarshan Pharma Industries is about ₹926.54 crore.
How did Sudarshan Pharma Industries perform in its latest quarterly results?
In the latest quarter (Jun 2026), Sudarshan Pharma Industries reported sales of ₹174.42 crore (+20.1%) and net profit of ₹5.61 crore (+41.7%), compared with the same quarter last year.
Is Sudarshan Pharma Industries a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Sudarshan Pharma Industries has a 3-year ROE of 14.00%, 3-year profit growth of 48.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Sudarshan Pharma Industries?
Promoters hold about 58.93% of Sudarshan Pharma Industries.
Which sector does Sudarshan Pharma Industries belong to?
Sudarshan Pharma Industries belongs to the Pharmaceuticals & Drugs sector.